Status In progress
Technology type Medicine
Decision Selected
Process STA Standard
ID number 1335

Email enquiries


Key events during the development of the guidance:

Date Update
28 November 2023 For information, the company have advised that they are no longer pursuing a Marketing Authorisation Application from the Medicines and Healthcare products Regulatory Agency for this indication at this time. Therefore, NICE has decided to suspend this appraisal from its current work programme. As this appraisal has been referred NICE will continue to monitor any development and will update interested parties if the situation changes.
24 April 2018 In progress. topics referred

For further information on our processes and methods, please see our CHTE processes and methods manual